Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients.
D'Ambra MN, Gray RJ, Hillman R, Jones JW, Kim HC, Rawitscher R, Schnaper H, Szymanski I, Vlahakes GJ, Kaplan D, Lynch KE, Guilfoyle M, Abels RI.
D'Ambra MN, et al. Among authors: guilfoyle m.
Ann Thorac Surg. 1997 Dec;64(6):1686-93. doi: 10.1016/s0003-4975(97)00839-4.
Ann Thorac Surg. 1997.
PMID: 9436556
Clinical Trial.